Middle East Pharmaceutical Industries TADAWUL:4016:
AVALON PHARMA Q3 SALES SAR 107.95 MILLION
AVALON PHARMA Q3 NET PROFIT SAR 8.28 MILLION
Avalon Pharma Q3 Profit SAR 8.28 Mln
Earlier from Middle East Pharmaceutical Industries
- ZAWYA: Saudi's Avalon Pharma renews $14mln credit with Saudi Investment Bank
- Middle East Pharmaceutical Industries H2 Dividend Per Share SAR 1.25